Mononuclear phagocyte hydrolytic enzyme activity associated with cerebral HIV-1 infection.

Por Gelman, B. B., Wolf, D. A., Rodriguez-Wolf, M., West, A. B., Haque, A. K., Cloyd, M.
Publicado em 1997

Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER)...

Por Biswas, B., Spitznagel, E., Collier, A.C., Gelman, B.B., McArthur, J.C., Morgello, S., McCutchan, J. A., Clifford, D.B.
Publicado em 2014

Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy

Por Robinson-Papp, J., Morgello, S., Vaida, F., Fitzsimons, C., Simpson, D.M., Elliott, K.J., Al-Lozi, M., Gelman, B.B., Clifford, D., Marra, C.M., McCutchan, J.A., Atkinson, J.H., Dworkin, R.H., Grant, I., Ellis, R.
Publicado em 2010

Defining Neurocognitive Impairment in HIV: Deficit Scores versus Clinical Ratings

Por Blackstone, K., Moore, D. J., Franklin, D. R., Clifford, D. B., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., Ellis, R. J., Atkinson, J. H., Grant, I., Heaton, R. K.
Publicado em 2012

Brain Morphometric Correlates of Metabolic Variables in HIV: The CHARTER Study

Por ARCHIBALD, S.L., MCCUTCHAN, J.A., SANDERS, C., WOLFSON, T., JERNIGAN, T.L., ELLIS, R.J., ANCES, B.M., COLLIER, A.C., MCARTHUR, J.C., MORGELLO, S., SIMPSON, D.M., MARRA, C., GELMAN, B.B., CLIFFORD, D.B., GRANT, I., FENNEMA-NOTESTINE, C.
Publicado no J Neurovirol (2014)

Diagnosing symptomatic HIV-associated neurocognitive disorders: Self-report versus performance-based assessment of everyday functioning

Por Blackstone, K., Moore, D. J., Heaton, R. K., Franklin, D. R., Woods, S. P., Clifford, D. B., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., Rivera-Mindt, M., Deutsch, R., Ellis, R. J., Atkinson, J. Hampton, Grant, I.
Publicado em 2011

Apolipoprotein E4 Genotype Does Not Increase Risk of HIV-associated Neurocognitive Disorders

Por Morgan, E.E., Woods, S.P., Letendre, S.L., Franklin, D.R., Bloss, C., Goate, A., Heaton, R.K., Collier, A.C., Marra, C.M., Gelman, B.B., McArthur, J.C., Morgello, S., Simpson, D.M., McCutchan, J.A., Ellis, R.J., Abramson, I., Gamst, A., Fennema-Notestine, C., Smith, D.M., Grant, I., Vaida, F., Clifford, D.B.
Publicado em 2013

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Por Heaton, R.K., Clifford, D.B., Franklin, D.R., Woods, S.P., Ake, C., Vaida, F., Ellis, R.J., Letendre, S.L., Marcotte, T.D., Atkinson, J.H., Rivera-Mindt, M., Vigil, O.R., Taylor, M.J., Collier, A.C., Marra, C.M., Gelman, B.B., McArthur, J.C., Morgello, S., Simpson, D.M., McCutchan, J.A., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T.L., Wong, J., Grant, I.
Publicado em 2010